Advanced Ultrasound in Diagnosis and Therapy ›› 2023, Vol. 7 ›› Issue (4): 321-332.doi: 10.37015/AUDT.2023.230041
• Review Articles • Previous Articles Next Articles
Osama Mahmoud, BSa, Ajay Makkena, BSa, Corinne E. Wessner, MS, MBA, RDMSb, Ji-Bin Liu, MDb, John R. Eisenbrey, PhDb, Andrej Lyshchik, MD, PhDb,*()
Received:
2023-06-21
Revised:
2023-07-21
Accepted:
2023-08-20
Online:
2023-12-30
Published:
2023-10-23
Contact:
Department of Radiology, Thomas Jefferson University, 7th Floor Main Building, 132 S. 10th Street, Philadelphia, PA 19107, USA. e-mail: Osama Mahmoud, BS, Ajay Makkena, BS, Corinne E. Wessner, MS, MBA, RDMS, Ji-Bin Liu, MD, John R. Eisenbrey, PhD, Andrej Lyshchik, MD, PhD. Contrast-Enhanced Ultrasound LI-RADS: A Pictorial Review. Advanced Ultrasound in Diagnosis and Therapy, 2023, 7(4): 321-332.
Figure 1
(A) Sagittal image of a hepatic segment 8 isoechoic solid observation measuring 28 mm; (B) At 22 seconds, the lesion demonstrates peripheral globular enhancement during the arterial phase; (C and D) At 1 minute and 5 minutes post injection show no washout with continued peripheral globular enhancement."
Figure 2
(A) Sagittal and transverse images of a hepatic segment 3 hyperechoic solid observation measuring 27 mm; (B) This image is at 25 seconds, demonstrating peripheral globular enhancement during the arterial phase with areas of non-enhancement; (C and D) Images obtained at 1- and 4-minutes post-injection showing iso-enhancement with no washout."
Figure 3
(A) Sagittal image of a hepatic segment 6 solid isoechoic observation measuring 37 mm; (B) This image is at 23 seconds, demonstrating global iso-enhancement during arterial phase; (C and D) Images obtained at 2- and 6-minutes post-injection show an iso-enhanced observation with no washout."
Figure 4
(A) Sagittal and transverse images of a hepatic segment 5 hyperechoic solid observation measuring 20 mm; (B) This image is at 17 seconds, demonstrating global iso-enhancement during the arterial phase; (C-E) Images obtained at 1-, 3-, and 5-minutes post-injection show iso-enhancement with no washout."
Figure 7
(A) Sagittal and transverse images of a hepatic segment 6 solid hyperechoic observation measuring 19 mm; (B) At 22 seconds the lesion demonstrates global hyper-enhancement during the arterial phase; (C and D) Images obtained at 1- and 4-minutes post-injection show an iso-enhanced observation with no washout."
Figure 8
(A) Sagittal and transverse images of a hepatic segment 6 with mixed echogenicity solid observation measuring 18 mm; (B) At 12 seconds the lesion demonstrates global hyper-enhancement during the arterial phase; (C-E) Images obtained at 1-, 2-, and 5-minutes post-injection show iso-enhancement with no washout."
Figure 9
(A) Sagittal and transverse images of a hepatic segment 2 solid isoechoic with circumscribed margins measuring 33 mm; (B) At 8 seconds the lesion demonstrates global hyper-enhancement during the arterial phase; (C and D) Images obtained at 4- and 7-minutes post-injection show mild weak washout."
Figure 12
(A) Sagittal and transverse images of a hepatic segment 8 infiltrative hypoechoic solid observation measuring 17 mm; (B) This image is at 12 seconds, demonstrating global hyper-enhancement during the arterial phase; (C-E) Images obtained at 2-, 3-, and 5-minutes post-injection, demonstrating mild washout."
Figure 14
(A) Sagittal and transverse images of a hepatic segment 8 mixed echogenicity solid observation measuring 32 mm; (B) This image is at 25 seconds. The image demonstrates global hyper-enhancement during arterial phase; (C) This image is at 50 seconds post-injection, showing marked washout; (D and E) Images obtained at 1- and 2-minutes post-injection continuously demonstrating marked washout."
[1] |
Rumgay H, Arnold M, Ferlay J, Lesi O, Cabasag CJ, Vignat J, et al. Global burden of primary liver cancer in 2020 and predictions to 2040. J Hepatol 2022; 77:1598-1606.
doi: 10.1016/j.jhep.2022.08.021 pmid: 36208844 |
[2] |
Ding J, Long L, Zhang X, Chen C, Zhou H, Zhou Y, et al. Contrast-enhanced ultrasound LI-RADS 2017: Comparison with CT/MRI LI-RADS. Eur Radiol 2021; 31:847-854.
doi: 10.1007/s00330-020-07159-z |
[3] |
Tan Z, Teoh WC, Wong KM, Wansaicheong GK, Sandrasegaran K. Analysis of comparative performance of CEUS and CECT/MR LI-RADS classification: Can CEUS dichotomize LI-RADS indeterminate lesions on CT or MRI? Clin Imaging 2020; 62:63-68.
doi: 10.1016/j.clinimag.2020.02.002 |
[4] |
Golabi P, Fazel S, Otgonsuren M, Sayiner M, Locklear CT, Younossi ZM. Mortality assessment of patients with hepatocellular carcinoma according to underlying disease and treatment modalities. Medicine (Baltimore) 2017; 96:e5904.
doi: 10.1097/MD.0000000000005904 |
[5] | Tunissiolli NM, Castanhole-Nunes MMU, Biselli-Chicote PM, Pavarino EC, da Silva RF, da Silva RC, et al. Hepatocellular carcinoma: A comprehensive review of biomarkers, clinical aspects, and therapy. Asian Pac J Cancer Prev 2017; 18:863-872. |
[6] | American College of Radiology. LI-RADS® CEUS v2017 | American College of Radiology. https://www.acr.org/-/media/ACR/Files/RADS/LI-RADS/CEUS-LI-RADS-2017-Core.pdf |
[7] |
Wilson SR, Lyshchik A, Piscaglia F, Cosgrove D, Jang HJ, Sirlin C, et al. CEUS LI-RADS: algorithm, implementation, and key differences from CT/MRI. Abdom Radiol (NY) 2018; 43:127-142.
doi: 10.1007/s00261-017-1250-0 pmid: 28819825 |
[8] |
Eisenbrey JR, Gabriel H, Savsani E, Lyshchik A. Contrast-enhanced ultrasound (CEUS) in HCC diagnosis and assessment of tumor response to locoregional therapies. Abdom Radiol (NY) 2021; 46:3579-3595.
doi: 10.1007/s00261-021-03059-y pmid: 33825927 |
[9] | Morgan TA, Maturen KE, Dahiya N, Sun MRM, Kamaya A. US LI-RADS: Ultrasound liver imaging reporting and data system for screening and surveillance of hepatocellular carcinoma. Abdom Radiol (NY) 2018; 43:41-55. |
[10] |
Chen LD, Ruan SM, Lin Y, Liang JY, Shen SL, Hu HT, et al. Comparison between M-score and LR-M in the reporting system of contrast-enhanced ultrasound LI-RADS. Eur Radiol 2019; 29:4249-4257.
doi: 10.1007/s00330-018-5927-8 pmid: 30569182 |
[11] | Li CQ, Huang H, Ruan SM, Hu HT, Xian MF, Xie XY, et al. An assessment of liver lesions using a combination of CEUS LI-RADS and AFP. Abdom Radiol (NY) 2022; 47:1311-1320. |
[12] | Zheng W, Li Q, Zou XB, Wang JW, Han F, Li F, et al. Evaluation of contrast-enhanced US LI-RADS version 2017: Application on 2020 liver nodules in patients with hepatitis B infection. Radiology 2020; 294:299-307. |
[13] |
Lyshchik A, Kono Y, Dietrich CF, Jang HJ, Kim TK, Piscaglia F, et al. Contrast-enhanced ultrasound of the liver: technical and lexicon recommendations from the ACR CEUS LI-RADS working group. Abdom Radiol (NY) 2018; 43:861-879.
doi: 10.1007/s00261-017-1392-0 pmid: 29151131 |
[14] |
Hu YX, Shen JX, Han J, Mao SY, Mao RS, Li Q, et al. Diagnosis of non-hepatocellular carcinoma malignancies in patients with risks for hepatocellular carcinoma: CEUS LI-RADS Versus CT/MRI LI-RADS. Front Oncol 2021; 11:641195.
doi: 10.3389/fonc.2021.641195 |
[15] |
Liu W, Qin J, Guo R, Xie S, Jiang H, Wang X, et al. Accuracy of the diagnostic evaluation of hepatocellular carcinoma with LI-RADS. Acta Radiol 2018; 59:140-146.
doi: 10.1177/0284185117716700 pmid: 28648125 |
[16] |
Terzi E, Iavarone M, Pompili M, Veronese L, Cabibbo G, Fraquelli M, et al. Contrast ultrasound LI-RADS LR-5 identifies hepatocellular carcinoma in cirrhosis in a multicenter retrospective study of 1,006 nodules. J Hepatol 2018; 68:485-492.
doi: 10.1016/j.jhep.2017.11.007 |
[17] |
Bartolotta TV, Terranova MC, Gagliardo C, Taibbi A. CEUS LI-RADS: a pictorial review. Insights Imaging 2020; 11:9.
doi: 10.1186/s13244-019-0819-2 |
[18] |
Kim DH, Choi SH, Park SH, Kim KW, Byun JH, Kim SY, et al. The Liver Imaging Reporting and Data System tumor-in-vein category: A systematic review and meta-analysis. Eur Radiol 2021; 31:2497-2506.
doi: 10.1007/s00330-020-07282-x |
[19] |
Nguyen SA, Merrill CD, Burrowes DP, Medellin GA, Wilson SR. Hepatocellular carcinoma in evolution: Correlation with CEUS LI-RADS. Radiographics 2022; 42:1028-1042.
doi: 10.1148/rg.210149 |
[20] |
Li W, Li L, Zhuang BW, Ruan SM, Hu HT, Huang Y, et al. Inter-reader agreement of CEUS LI-RADS among radiologists with different levels of experience. European Radiology 2021; 31:6758-6767.
doi: 10.1007/s00330-021-07777-1 pmid: 33675388 |
[21] | Sugimoto K, Kakegawa T, Takahashi H, Tomita Y, Abe M, Yoshimasu Y, et al. Usefulness of modified CEUS LI-RADS for the diagnosis of hepatocellular carcinoma using Sonazoid. Diagnostics (Basel) 2020; 10:828. |
[22] |
Schellhaas B, Hammon M, Strobel D, Pfeifer L, Kielisch C, Goertz RS, et al. Interobserver and intermodality agreement of standardized algorithms for non-invasive diagnosis of hepatocellular carcinoma in high-risk patients: CEUS-LI-RADS versus MRI-LI-RADS. Eur Radiol 2018; 28:4254-4264.
doi: 10.1007/s00330-018-5379-1 pmid: 29675659 |
[23] | Quaia E. State of the art: LI-RADS for contrast-enhanced US. Radiology 2019;293. |
[24] | World Health Organization. Number of new cases and deaths from liver cancer is predicted to rise by more than 55% by 2040. https://www.iarc.who.int/news-events/number-of-new-cases-and-deaths-from-liver-cancer-predicted-to-rise-by-more-than-55-by-2040/ |
[1] | Priscilla Machado, MD, Ji-Bin Liu, MD, Flemming Forsberg, PhD. Sentinel Lymph Node Identification Using Contrast Lymphosonography: A Systematic Review [J]. Advanced Ultrasound in Diagnosis and Therapy, 2023, 7(1): 1-7. |
[2] | Ping Wang, MM, Yuqun Luo, MM, Yunkai Li, MM, Wensheng Yue, MD, Duo Huang, MD, Xuemei Lin, MM, Shaoli Xie, MM, Bin Xiong, MM. A Misdiagnosed Cervical Vagal Schwannoma: A Case Report and Review of Its Imaging Features and Differential Diagnosis [J]. Advanced Ultrasound in Diagnosis and Therapy, 2023, 7(1): 53-56. |
[3] | Felipe Velasquez-Botero, MD, Ananya Balasubramanya, Ying Tang, MD, Qiang Lu, MD, Ji-Bin Liu, MD, John R. Eisenbrey, PhD. Renal Contrast-enhanced Ultrasound: Clinical Applications and Emerging Research [J]. Advanced Ultrasound in Diagnosis and Therapy, 2022, 6(4): 129-146. |
[4] | Yanling Chen, MM, Hantao Wang, MM, Hong Han, PhD, Yi Dong, PhD, Wen-ping Wang, MD. Contrast-enhanced Ultrasound of Undifferentiated Embryonal Sarcoma of the Liver in Adult: Two Cases Report and Literature Review [J]. Advanced Ultrasound in Diagnosis and Therapy, 2022, 6(4): 204-209. |
[5] | Huolin Ye, MD, Qiannan Huang, MD, Qingjing Zeng, MD, Xuqi He, MD, Erjiao Xu, MD, Yinglin Long, MD, Kai Li, MD, Rongqin Zheng, MD. Contrast-enhanced Ultrasound for Evaluation of Active Needle Tract Bleeding during Thermal Ablation of Liver Cancer [J]. Advanced Ultrasound in Diagnosis and Therapy, 2022, 6(3): 104-111. |
[6] | Brenda E. Tester, BS, MS, Ji-Bin Liu, MD, John R. Eisenbrey, PhD, George Koenig, MD. Emerging Applications of Contrast-enhanced Ultrasound in Trauma [J]. Advanced Ultrasound in Diagnosis and Therapy, 2022, 6(2): 39-47. |
[7] | Xuehong Diao, MD, Lin Chen, MD, Bo Yu, MS, Jiamei Jin, MS, Jia Zhan, MD, Yue Chen, BS. Follicular Thyroid Neoplasmon Conventional and Contrast-enhanced Ultrasound [J]. Advanced Ultrasound in Diagnosis and Therapy, 2022, 6(2): 48-57. |
[8] | Tong Zhang, MD, Xiaolin Yin, Shuang Zheng, MD, Mingwei Sui, MD, Dezhi Zhang, MD. Application Value of Two-Dimensional Ultrasound Combined with Contrast-Enhanced Ultrasound for the Diagnosis of Multiple Bile Duct Hamartomas: A Case Report [J]. Advanced Ultrasound in Diagnosis and Therapy, 2021, 5(4): 317-320. |
[9] | Esika Savsani, Mohamed Tantawi, MD, Corinne E. Wessner, MBA, RDMS, RVT, Philip Lee, MD, Andrej Lyshchik, MD, PhD, Kevin Anton, MD, PhD, Colette M. Shaw, MD, Ji-Bin Liu, MD, John R. Eisenbrey, PhD. Contrast-enhanced Ultrasound Assessment of Treatment Response in a Patient with Multifocal Hepatocellular Carcinoma Treated with Transarterial Chemo and Radioembolization [J]. Advanced Ultrasound in Diagnosis and Therapy, 2021, 5(3): 254-257. |
[10] | Yan Zhou, Jianmin Ding, Fengmei Wang, Zhengyi Qin, Yandong Wang, Hongyu Zhou, Xiang Jing. The Effects of Liver Function Damage after Thermal Ablation on the Prognosis of HCC Patients and Its Prediction [J]. Advanced Ultrasound in Diagnosis and Therapy, 2021, 5(2): 80-86. |
[11] | Mengna He, MD, PHD, Lu Zhu, MD, Tianan Jiang, MD, PHD. Findings of Fat Containing Hepatocellular Carcinoma on Contrast-enhanced Ultrasound with Sonazoid: A Case Report [J]. Advanced Ultrasound in Diagnosis and Therapy, 2021, 5(2): 98-101. |
[12] | Danni He, MS, Qiao Ji, MD, Huitong Lin, MD, Xuankun Liang, MM, Lujing Li, MM, Fengping Liang, MM, Xianxiang Wang, MM, Kun Yuan, MS, Zuofeng Xu, MD. A New-Designed Microwave Ablation System: Testing in ex vivo and in vivo Liver Model [J]. Advanced Ultrasound in Diagnosis and Therapy, 2021, 5(1): 39-46. |
[13] | Mohamed Tantawi, MD, Ji-Bin Liu, MD, John R Eisenbrey, PhD. Recent Advances in Microbubble-Augmented Cancer Therapy [J]. Advanced Ultrasound in Diagnosis and Therapy, 2020, 4(3): 155-168. |
[14] | Qiuyang Li, MD, Ying Zhang, MD, Yong Song, MD, Aitao Guo, MD, Nan Li, BS, Yukun Luo, MD, Jie Tang, MD. Clinical Application of Ultrasound in the Diagnosis and Treatment of Reninoma [J]. Advanced Ultrasound in Diagnosis and Therapy, 2020, 4(3): 211-216. |
[15] | Mengna He, MD, PhD, Lei Xu, MD, Tian’an Jiang, MD, PhD. Time-intensity Curve Analysis of Hepatocellular Carcinoma using Two Contrast-enhanced Ultrasound Methods: Contrast Pulse Sequencing and Contrast Harmonic Imaging [J]. Advanced Ultrasound in Diagnosis and Therapy, 2020, 4(3): 217-222. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||
Share: WeChat
Copyright ©2018 Advanced Ultrasound in Diagnosis and Therapy
|
Advanced Ultrasound in Diagnosis and Therapy (AUDT) a> is licensed under a Creative Commons Attribution 4.0 International License a>.